 ARLINGTON, Mass., March 23, 2022 GLOBE NEWSWIRE -- Kala Pharmaceuticals, Inc. NASDAQ:KALA, a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report fourth quarter and full year 2021 financial results on Tuesday, March 29, 2022. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 8:00 a.m. ET. 